Board Meetings for AJANTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AJANTPHARM | Ajanta Pharma Limited | 05 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 | |
| AJANTPHARM | Ajanta Pharma Limited | 05 May 2026 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 05-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2026 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2025 | Dividend | To consider dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2025 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Jul 2025 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 28-Jul-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Jul 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Apr 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Apr 2025 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Apr-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 . | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Jan 2025 | Board Meeting Intimation | AJANTA PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Oct 2024 | Dividend | To consider dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Oct 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and dividend |
Showing page 1 of 8 (113 total items)